Small Stocks BIG Returns

BlackBerry Awarded AAA Rating in SE Labs' Breach Response Test
SmallCap Network /

Feb 5, 2022

/

08:50 PM PST

Rating

No ratings

BlackBerry Protect and Optics provided 100% prevention, 100% detection and zero false positives


 BlackBerry Limited (NYSE: BB; TSX: BB) today announced the results from SE Labs' Breach Response test on BlackBerry® Protect and BlackBerry® Optics, its AI-driven endpoint protection (EPP) and endpoint detection and response (EDR) products. The combined EPP and EDR solution was able to provide complete prevention, complete detection, and zero false positive results, earning SE Lab's maximum AAA rating for its excellent performance.


 

Comment (0)

Read More
The Product Launches Sending Sonoma Pharmaceuticals Soaring Today
SmallCap Network /

Apr 5, 2022

/

06:10 PM PST

Rating

No ratings

The launch sending SNOA stock up today covers two new dental products: OroGenix Oral Hygiene Rinse and Microdacyn Oral Care. These products are for use by professionals, as well as consumers in some cases.OroGenix Oral Hygiene Rinse is the second dental product by Sonoma Pharmaceuticals in the U.S. It was developed with the help of partner Gabriel Science. The new product is an oral hygiene rinse that uses Sonoma Pharmaceuticals’ Microcyn tech to clean teeth, gums, and the mouth.Microdacyn Oral Care isn’t coming to the U.S. and is instead launching in Switzerland. This product is designed to “combat oral and pharyngeal infections and inflammation, and reduce pain and coughing.”The Top 7 Stocks to Buy for Under $20 in AugustBruce Thornton, COO of Sonoma Pharmaceuticals, said this about the news boosting SNOA stock higher today.“We are pleased to bring the oral rinse to dental offices in the U.S., and for both professional and consumer use in Europe.

Comment (0)

Read More
PharmaCyte Biotech Releases Statement on Nasdaq Uplisting and Current Business Focus
SmallCap Network /

Mar 4, 2022

/

04:22 PM PST

Rating

No ratings



LAGUNA HILLS, Calif.--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (NASDAQ: PMCB) (PharmaCyte or Company), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today released a statement from Kenneth L. Waggoner, the Chief Executive Officer of PharmaCyte, regarding the Company’s recent listing on Nasdaq and the Company’s current business focus.

Comment (0)

Read More
Relevium to commercialize Bioganix® cleancare hand sanitizers
SmallCap Network /

Jun 26, 2022

/

11:58 AM PST

Rating

No ratings

MONTREAL, April 02, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today it has sourced and will begin commercializing a line of Bioganix® hand sanitizers.Relevium is leveraging its strong network of suppliers and formulators to manufacture and bring to market a line of hand sanitizers under the Bioganix ® Cleancare. The Company will have an initial format of 8oz (235ml) that will effectively kill 99.9% of germs and bacteria. The product is formulated and manufactured in Miami, Florida at the Company's specialty products contract manufacturing partner and will be sold both online and through selected retail chains in the US.

Comment (0)

Read More
BacTech Environmental Outlines Plans For 2020
SmallCap Network /

Apr 9, 2022

/

06:32 PM PST

Rating

No ratings

Toronto, Canada: BacTech Environmental Corporation (CSE:BAC, OTC:BCCEF) today announced its plans for the current year with respect to the Ecuador project.



BacTech has identified the Ponce Enriquez area of southern Ecuador as an area where the Company’s bioleaching technology can be deployed for environmental processing of locally produced concentrates. Given the high levels of arsenic contained in the ore from the area, miners receive depressed prices for their concentrates due to penalties applied by the buyers. The buyers tend to be from Asia whereby concentrates are shipped for conventional smelting and/or roasting. The concentrates are subject to a 3% royalty on the gold value payable to the government of Ecuador. As well, shipping and handling add to the costs of pursuing this avenue. BacTech believes it can offer superior pricing for these concentrates, employment opportunities and payment of local and federal taxes. It should be noted that the final arsenic product produced from bioleaching, ferric arsenate, is a US, Environmental Protection Agency approved land fillable form of arsenic.

Comment (0)

Read More
<<1  2  3  4  5  6  7  8  9  10  >>